基本信息
浏览量:41
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Miraz Rahman is a Professor of Medicinal Chemistry in School of Cancer & Pharmaceutical Sciences, King’s College London. After working three years in the industry, he went back to academia and obtained his PhD from the School of Pharmacy (currently UCL School of Pharmacy) in synthetic medicinal chemistry. His research activities are focused on the application of advanced computational chemistry, synthetic medicinal chemistry and chemical biology techniques to the design, synthesis and evaluation of novel drug-like chemical scaffolds as anticancer and anti-infective agents. He joined King’s College London in 2012 and currently holds the position of Chair in Medicinal Chemistry and Antimicrobial Research Theme Lead of Institute of Pharmaceutical Science. He is working with UK Health Security Agency to develop new generation efflux resistant antimicrobials and new chemical tools to study antimicrobial resistance (AMR). His research group has invented new classes of efflux resistant antibiotics and antifungal agents that are currently being commercialised. Professor Rahman has experience in both early and late-stage drug discovery and translational research, co-founding Transcriptogen Ltd (2013), Femtogenix Ltd (2015) and the antibiotic company Necobiotix Ltd (2020).
研究兴趣
论文共 195 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
RSC CHEMICAL BIOLOGYno. 5 (2024): 395-396
Grace Ruiz-Lara,Tales A Costa-Silva, Jorge Javier Muso-Cachumba, Johanna Cevallos Espinel, Marina Gabriel Fontes,Mitla Garcia-Maya,Khondaker Miraz Rahman,Carlota de Oliveira Rangel-Yagui,Gisele Monteiro
International journal of molecular sciencesno. 11 (2024): 6008
Anthony Cheung,Alicia M Chenoweth,Annelie Johansson,Roman Laddach,Naomi Guppy, Jennifer Trendell, Benjamina Esapa, Antranik Mavousian, Blanca Navarro-Llinas,Syed Haider, Pablo Romero-Clavijo,Ricarda M Hoffmann,
Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
BRITISH JOURNAL OF PHARMACOLOGYno. 4 (2024): 580-592
James Stewart,Jakaria Shawon,Md Ackas Ali, Blaise Williams, A. D. A. Shahinuzzaman, Sharmin Akther Rupa,Taha Al-Adhami, Ruoqing Jia, Cole Bourque, Ryan Faddis, Kaylee Stone,Md Abu Sufian,
Anusha Gauba,Khondaker Miraz Rahman
ANTIBIOTICS-BASELno. 11 (2023): 1590-1590
Sevda T. Boyanova, Ethlyn Lloyd-Morris,Christopher Corpe,K. Miraz Rahman,Doaa B. Farag, Lee K. Page, Hao Wang,Alice L. Fleckney,Ariana Gatt,Claire Troakes, Gema Vizcay-Barrena,Roland Fleck,
Meriem Bahri,Taha Al-Adhami, Emre Demirel,Joanne E. Anstee, Karen T. Feehan, James Rosekilly,Cheryl E. Gillett,Dominika Sosnowska, Renee Gitsaki-Taylor,Tik Shing Cheung,James F. Spicer,Khondaker Miraz Rahman,
CANCER IMMUNOLOGY RESEARCHno. 12 (2023)
BRITISH JOURNAL OF PHARMACOLOGY (2023): 687-687
引用0浏览0引用
0
0
RSC chemical biologyno. 1 (2023): 94-100
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn